Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Larimar Therapeutics' 2026 Annual Meeting held on May 19, 2026. The filing reports final voting tallies for six proposals: election of three Class III directors (Frank Thomas, Carole S. Ben-Maimon, M.D., and Joseph Truitt), advisory approval of named executive officer compensation, advisory frequency vote on compensation (one year preferred), ratification of PricewaterhouseCoopers LLP as independent auditor, approval of an amendment to increase authorized common shares from 115 million to 215 million, and approval of an adjournment. All proposals passed with substantial majorities. This is material as it confirms board composition and shareholder approval of key governance and capital structure matters.
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Millrose Properties' annual stockholder meeting held on May 18, 2026. The filing presents detailed vote tallies for two proposals: election of five directors (Carlos A. Migoya, Patrick J. Bartels, Kathleen B. Lynch, Matthew B. Gorson, and M. Alison Mincey) and ratification of Deloitte & Touche LLP as independent auditor. All directors were elected and the auditor ratification passed by overwhelming margins, making this a material governance event that affects investor understanding of board composition and audit oversight.
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from Nucor's May 14, 2026 annual meeting. The filing reports voting outcomes for three proposals: election of eight directors (all passed with strong majorities), ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. The detailed vote tallies and passage of all proposals are the core content of this 8-K section.
View raw filing on EDGAR →
M&A activity
confidence 85%
filed 2026-05-19
Item 1.01
The filing discloses entry into material definitive agreements in connection with Blackstone Digital Infrastructure Trust's initial public offering on May 15, 2026, including a Registration Rights Agreement, Management Agreement, and a $1.0 billion senior secured revolving credit facility. While the IPO itself is the primary capital-raising event, Item 1.01 specifically covers the entry into material definitive agreements, and the $1.0 billion credit facility with expansion capacity to $4.0 billion represents a material financing arrangement that would affect investor assessment of the company's capital structure and financial flexibility.
View raw filing on EDGAR →
Other material
confidence 45%
filed 2026-05-19
Item 3.03
Item 3.03 discloses a material modification to rights of security holders, with the substance incorporated by reference from Item 5.03. Without access to Item 5.03's content, the specific nature of the modification cannot be determined. Item 5.03 typically covers amendments to articles of incorporation or bylaws; if the modification materially affects shareholder voting, dividend, or liquidation rights, it would be material. Given the cross-reference structure and the Item 3.03 designation itself, this is classified as material but assigned to "other_material" due to insufficient detail to identify a more specific event type.
View raw filing on EDGAR →
Exec Compensation
confidence 92%
filed 2026-05-19
Item 5.02
The disclosure centers on the Board's adoption of the Blackstone Digital Infrastructure Trust Inc. Stock Incentive Plan on May 13, 2026. This is a compensatory arrangement for officers and directors — a long-term incentive plan governing equity grants. The filing explicitly references "Executive and Director Compensation — Long-Term Incentive Plan" in the Prospectus, confirming this is a material compensation plan adoption rather than a personnel change.
View raw filing on EDGAR →
Dilutive issuance
confidence 85%
filed 2026-05-19
Item 8.01
The filing discloses completion of an initial public offering of 87.5 million shares at $20.00 per share, with underwriters exercising a full 30-day option for additional shares, resulting in gross proceeds of $2.0 billion. While this is technically a registered offering (not an unregistered private placement), the massive capital raise and resulting dilution to investors is material and represents the company's entry into public markets. The dilutive_issuance category best captures the equity issuance event, though this is a registered IPO rather than a typical PIPE or private placement.
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of the 2026 Annual Meeting of Stockholders held on May 15, 2026. The filing presents voting results for three proposals: election of three Class III directors (Edgar R. Giesinger, A. James Teague, and William A. Zartler), ratification of BDO USA, P.C. as independent auditor, and an advisory vote on named executive officer compensation. These are routine but material shareholder votes that affect board composition and auditor appointment.
View raw filing on EDGAR →
Exec appointment
confidence 95%
filed 2026-05-19
Item 5.02
The filing discloses the appointment of Andrea Brimmer to the Board of Directors of Primo Brands Corporation, effective May 15, 2026, to fill a newly created vacancy. While the Board size increase is administrative, the principal disclosed action is the appointment of a director with significant executive experience (Chief Marketing and Public Relations Officer at Ally Financial Inc. since 2015) and board service at other public companies. This is a material corporate governance event affecting the composition of the Board.
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a clear Item 5.07 disclosure of shareholder voting results from Eastern Bankshares' May 18, 2026 annual meeting. The filing reports the outcomes of three proposals: election of six directors, advisory vote on executive compensation, and ratification of Ernst & Young LLP as independent auditor. All three votes passed with substantial majorities, and the detailed vote tallies (votes for, against, abstentions, and broker non-votes) are provided for each proposal.
View raw filing on EDGAR →
Exec Compensation
confidence 92%
filed 2026-05-19
Item 5.02
The disclosure centers on stockholder approval of an amendment to the 2017 Equity Incentive Plan increasing authorized shares from 5,000,000 to 7,000,000. This is a compensatory arrangement amendment affecting the pool of equity available for executive and employee grants, which is a material disclosure under Item 5.02(e) and would affect investor assessment of dilution and compensation capacity.
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a clear disclosure of shareholder voting results from the Company's Annual Meeting held on May 13, 2026. The filing presents final voting tallies for five proposals: election of five directors, ratification of auditors (Haskell & White LLP), approval of a stock plan amendment increasing authorized shares from 5,000,000 to 7,000,000, advisory approval of named executive officer compensation, and approval of meeting adjournment. All proposals passed. This is a quintessential Item 5.07 disclosure and is material to investors as it confirms the composition of the board and key governance decisions.
View raw filing on EDGAR →
Earnings release
confidence 95%
filed 2026-05-19
Item 2.02
IRIDEX Corporation issued a press release on May 19, 2026 disclosing financial results for its first fiscal quarter ended April 4, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a standard quarterly earnings release, which is material to investors as it provides key financial performance metrics and operational updates.
View raw filing on EDGAR →
M&A activity
confidence 75%
filed 2026-05-19
Item 1.01
HPS Corporate Lending Fund entered into a material definitive agreement on May 19, 2026, to issue $600 million in aggregate principal amount of 6.300% notes due 2031, with net proceeds of approximately $594.3 million. While this is technically a debt issuance rather than a traditional M&A transaction, Item 1.01 captures "entry into a material definitive agreement," and the Fund's stated use of proceeds—to make investments, reduce borrowings, and repay indebtedness—reflects a material capital structure and financing event that would affect a reasonable investor's assessment of the registrant's financial position and strategy.
View raw filing on EDGAR →
Other material
confidence 65%
filed 2026-05-19
Item 2.03
Item 2.03 discloses creation of a direct financial obligation, with details incorporated by reference from Item 1.01 (Notes Offering). Without access to the full Item 1.01 text, the nature of the obligation cannot be precisely determined. However, a notes offering by a corporate lending fund creates a material debt obligation. This does not fit the more specific categories (covenant_breach requires a triggering event; ma_activity requires acquisition/disposition), so other_material is most appropriate pending review of the referenced Item 1.01 details.
View raw filing on EDGAR →
M&A activity
confidence 75%
filed 2026-05-19
Item 1.01
Patterson-UTI Energy completed a $500 million offering of senior notes on May 19, 2026, pursuant to a supplemental indenture dated the same day. While this is a debt issuance rather than a traditional M&A transaction, it represents a material capital structure event involving entry into a definitive agreement (the Supplemental Indenture) that materially affects the company's financial obligations and liquidity. The company intends to use proceeds to redeem existing debt and for general corporate purposes, making this a material financing event that would affect investor assessment of the registrant's capital structure and financial position.
View raw filing on EDGAR →
Other material
confidence 45%
filed 2026-05-19
Item 2.03
Item 2.03 discloses creation of a direct financial obligation, with the substance incorporated by reference from Item 1.01. Without access to Item 1.01, the specific nature of the obligation cannot be determined. Item 1.01 typically covers M&A activity, but could also involve debt issuance, lease arrangements, or other material financial commitments. Given the materiality threshold of Item 2.03 and the cross-reference structure, this is material but cannot be classified into a more specific category without the referenced Item 1.01 content.
View raw filing on EDGAR →
Dilutive issuance
confidence 95%
filed 2026-05-19
Item 3.02
Apollo Debt Solutions BDC sold 384,867 unregistered Class I Common Shares for $9.2 million to feeder vehicles, relying on Section 4(a)(2) and Regulation S exemptions. This is a classic dilutive private placement of equity securities that would materially affect shareholder ownership and the total mix of information available to investors regarding capitalization and dilution.
View raw filing on EDGAR →
Other material
confidence 72%
filed 2026-05-19
Item 7.01
This Item 7.01 disclosure announces May 2026 distributions declared on May 19, 2026, with per-share amounts ranging from $0.1627 to $0.1800 across three share classes, payable June 29, 2026. While routine distribution announcements are typically administrative, the accompanying portfolio and business commentary—including NAV, performance metrics, portfolio composition ($25.7B across 404 companies), leverage ratios, and recent transaction highlights (Sabre, Qualus)—constitutes material supplemental disclosure that would affect a reasonable investor's assessment of the fund's financial condition and performance. The disclosure does not fit neatly into the specific event-type taxonomy (not earnings_release, not exec-related, not M&A, not a restatement or covenant breach), making other_material the most appropriate classification.
View raw filing on EDGAR →
Other material
confidence 65%
filed 2026-05-19
Item 8.01
This Item 8.01 disclosure provides a Net Asset Value and Portfolio Update for Apollo Debt Solutions BDC as of April 30, 2026, including NAV per share ($23.92 across all classes), aggregate NAV ($14.5 billion), portfolio fair value ($25.7 billion), debt outstanding ($11.8 billion), and leverage ratios (0.81x debt-to-equity, 0.75x net leverage). While NAV updates and offering status are routine for BDCs, the disclosure of material portfolio metrics and leverage ratios would be relevant to investors assessing the fund's financial position and risk profile. However, this does not fit cleanly into any specific event category (not earnings, M&A, impairment, covenant breach, or other defined events), making "other_material" the most appropriate classification.
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a clear disclosure of shareholder voting results from ATI Inc.'s 2026 Annual Meeting of Stockholders held on May 14, 2026. The filing presents detailed vote tallies for three proposals: election of three directors (Kimberly A. Fields, Elizabeth H. Lund, and David J. Morehouse), an advisory vote on named executive officer compensation, and ratification of Ernst & Young LLP as independent auditors. This is a quintessential Item 5.07 disclosure and is material to investors as it documents the outcomes of fundamental corporate governance matters.
View raw filing on EDGAR →
Exec appointment
confidence 95%
filed 2026-05-19
Item 5.02
The filing discloses the appointment of Jeff Newgard as President and Chief Executive Officer of GBank effective June 8, 2026, with detailed compensation terms including a $500,000 base salary, $100,000 sign-on bonus, equity grants of 20,000 restricted shares, and relocation assistance. While the section also mentions A. Lee Finley's resignation as a director, the principal and substantive disclosure centers on the executive appointment with comprehensive employment agreement details. This is a material executive appointment that would affect investor assessment of company leadership.
View raw filing on EDGAR →
Exec Compensation
confidence 92%
filed 2026-05-19
Item 5.02
The disclosure centers on stockholder approval of amendments to two equity incentive plans: the 1996 Equity Incentive Plan (increasing available shares by 2,000,000) and the 2019 Employee Stock Purchase Plan (increasing available shares by 500,000). These are compensatory arrangements affecting equity grants and employee stock purchase eligibility, which fall squarely within exec_compensation. The material increase in share authorization and plan modifications would affect investor assessment of dilution and executive compensation capacity.
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on May 14, 2026. The filing presents detailed voting tallies for five proposals: election of ten directors, ratification of KPMG LLP as auditor, advisory approval of executive compensation, and approval of amendments to the 1996 Equity Incentive Plan and 2019 Employee Stock Purchase Plan. All proposals passed with substantial majorities, making this a material disclosure of governance outcomes.
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Invivyd's Annual Meeting of Stockholders held on May 19, 2026. The filing presents voting tallies for two proposals: (1) election of six directors (Tamsin Berry, Paul B. Bolno, Marc Elia, Terrance McGuire, Kevin F. McLaughlin, and Ajay Royan) for one-year terms, and (2) ratification of PricewaterhouseCoopers LLP as independent auditor. All nominees were elected and the auditor ratification passed with overwhelming support, making this a material governance event that investors rely on to understand board composition and audit oversight.
View raw filing on EDGAR →
Dilutive issuance
confidence 75%
filed 2026-05-19
Item 8.01
The Company converted 42,839.11 shares of Series B Non-Voting Convertible Preferred Stock into 42,839,103 shares of common stock on May 15, 2026, resulting in a substantial increase in common share count (approximately 1,000x conversion ratio). This mandatory conversion of preferred stock into common stock is a dilutive issuance that materially increases the equity base and would affect a reasonable investor's assessment of ownership dilution and voting power, even though the conversion was contractually mandated under the Certificate of Designation.
View raw filing on EDGAR →
Delisting risk
confidence 95%
filed 2026-05-19
Item 3.01
The filing discloses that Nasdaq has notified Bitcoin Depot that trading of its Class A common stock and warrants will be suspended effective May 26, 2026, and a Form 25-NSE will be filed to remove the securities from listing and registration on Nasdaq. This is a direct delisting notice triggered by the company's Chapter 11 bankruptcy filing and failure to timely file its Form 10-Q, making this a clear delisting_risk event under Item 3.01.
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from CTS Corporation's Annual Meeting of Shareholders held on May 14, 2026. The filing reports final voting tallies for three proposals: election of eight directors (all elected), advisory approval of named executive officer compensation (approved), and ratification of Grant Thornton as independent auditor (approved). Shareholder voting outcomes are material to investors as they reflect governance decisions and stakeholder approval of key corporate matters.
View raw filing on EDGAR →
Exec Compensation
confidence 95%
filed 2026-05-19
Item 5.02
This Item 5.02 disclosure centers on shareholder approval of amendments to two compensation plans: the 2021 Incentive Plan (adding 14.15 million shares and modifying vesting requirements) and the Employee Stock Purchase Plan (adding 1 million shares and increasing discount from 10% to 15%). These are compensatory arrangements affecting directors, officers, and employees, making this an exec_compensation event rather than a routine administrative matter.
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a clear disclosure of shareholder vote results from Roper Technologies' Annual Meeting held May 19, 2026. The filing reports voting outcomes for six proposals: election of nine directors (all approved), advisory compensation vote (approved), auditor ratification (approved), incentive plan amendment (approved), employee stock purchase plan amendment (approved), and a shareholder proposal on spin-off strategic review (not approved). This is a quintessential Item 5.07 disclosure with detailed vote tallies for each proposal.
View raw filing on EDGAR →
Other material
confidence 75%
filed 2026-05-19
Item 5.03
The disclosure describes stockholder-approved amendments to the Restated Certificate of Incorporation removing supermajority voting requirements and limitations on special meetings, along with conforming bylaw amendments. While Item 5.03 is the standard disclosure vehicle for charter and bylaw amendments, these changes materially alter the Company's governance structure by reducing voting thresholds and expanding stockholder rights to call special meetings—changes that would affect a reasonable investor's assessment of corporate control and governance. This does not fit the more specific event types in the taxonomy.
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a classic Item 5.07 disclosure of shareholder meeting results. The filing reports voting outcomes from the May 15, 2026 Annual Meeting across seven proposals, including director elections (Brian T. Carley, Femida H. Gwadry-Sridhar, Robert O. Kraft, August J. Troendle, Dani S. Zander), ratification of Deloitte & Touche LLP as auditor, advisory votes on executive compensation and voting frequency, and two Certificate of Incorporation amendments. The detailed vote tallies and Board determination regarding annual advisory votes on compensation are material to investors assessing governance and board composition.
View raw filing on EDGAR →
M&A activity
confidence 92%
filed 2026-05-19
Item 7.01
The Trust disclosed receipt of a Schedule 13D filed by SoftVest relating to a "proposed business combination involving the Trust." The disclosure explicitly references a potential merger or change-of-control transaction, with anticipated Form S-4 filing and unitholder meeting. This constitutes material M&A activity under Item 1.01 or 2.01 framework, even though disclosed via Item 7.01 (Regulation FD).
View raw filing on EDGAR →
Other material
confidence 72%
filed 2026-05-19
Item 8.01
Kennametal announced a cash tender offer for its 4.625% Senior Notes due 2028 and a concurrent underwritten public offering of senior notes. While this involves debt refinancing activity, it does not fit cleanly into the M&A taxonomy (which focuses on acquisitions, dispositions, mergers, or changes of control). The tender offer and new debt issuance are material financing transactions that would affect investor assessment of the company's capital structure and liquidity, but lack a more specific event classification.
View raw filing on EDGAR →
M&A activity
confidence 95%
filed 2026-05-19
Item 1.01
The filing discloses entry into Amendment No. 7 to the Company's credit agreement in connection with the "consummation of the Merger," with a $900 million senior secured first lien incremental term loan facility to fund aggregate consideration to stockholders and transaction expenses. This is a material acquisition or change-of-control event disclosed under Item 1.01, evidenced by the merger financing and stockholder consideration language.
View raw filing on EDGAR →
M&A activity
confidence 92%
filed 2026-05-19
Item 1.02
The filing discloses termination of a stockholders agreement "in connection with the consummation of the Merger," indicating a merger or change-of-control transaction has closed. Item 1.02 covers termination of material definitive agreements, but the material event here is the underlying merger completion. The termination of the stockholders agreement is a consequence of the merger consummation, making this a material acquisition/change-of-control event that would significantly affect investor assessment of the registrant.
View raw filing on EDGAR →
M&A activity
confidence 98%
filed 2026-05-19
Item 2.01
This Item 2.01 discloses the completion of a merger in which Mister Car Wash, Inc. was acquired at $7.00 per share in cash. The filing describes the Effective Time of the Merger, conversion of common stock into cash consideration, treatment of equity awards, and termination of equity plans—all hallmarks of a completed change-of-control transaction. The language "At the effective time of the Merger" and detailed mechanics of stock conversion confirm consummation of a material acquisition.
View raw filing on EDGAR →
M&A activity
confidence 75%
filed 2026-05-19
Item 2.03
Item 2.03 incorporates Item 1.01 by reference, which covers material acquisitions, dispositions, mergers, or changes of control. The cross-reference structure indicates a significant M&A transaction or financing arrangement that creates direct financial obligations. Without the full Item 1.01 text, ma_activity is the most likely material event triggering Item 2.03 disclosure.
View raw filing on EDGAR →
Delisting risk
confidence 95%
filed 2026-05-19
Item 3.01
The filing explicitly discloses that on May 19, 2026, Mister Car Wash notified NASDAQ of a certificate of merger and requested delisting of its common stock (ticker "MCW") from NASDAQ via Form 25 filing with the SEC. Trading was suspended prior to market open on May 19, 2026, and the company intends to file Form 15 to deregister and terminate reporting obligations. This is a material delisting event triggered by a merger consummation.
View raw filing on EDGAR →
M&A activity
confidence 95%
filed 2026-05-19
Item 3.03
Item 3.03 discloses material modification to security holder rights arising from a merger completion. The prose describes the "Effective Time" of a merger, the cessation of stockholder rights, and the substitution of merger consideration (Per Share Price) and appraisal rights under DGCL Section 262. This is the terminal event of a material acquisition/merger, which is incorporated by reference from Item 2.01 (Completion of Acquisition or Disposition of Assets) and Item 5.01 (Changes in Control of Registrant).
View raw filing on EDGAR →
M&A activity
confidence 75%
filed 2026-05-19
Item 5.02
The filing discloses the consummation of a Merger with multiple material consequences: nine directors resigned effective at the Effective Time, one director remained and one was appointed, and all Company Equity Plans were terminated. While the section also mentions cash transaction bonuses to named executive officers, the dominant disclosed event is the completion of the Merger and its immediate corporate governance and equity plan consequences. The language "In connection with the consummation of the Merger" and "effective as of the Effective Time" indicates this is a post-closing disclosure of a material acquisition or change of control event.
View raw filing on EDGAR →
M&A activity
confidence 95%
filed 2026-05-19
Item 5.03
Although Item 5.03 nominally addresses amendments to articles and bylaws, the disclosure explicitly references a "Merger Agreement" and states that amendments occurred "at the Effective Time" of a merger, with incorporation by reference to Item 2.01 (which covers material acquisitions and mergers). The complete restatement of both certificate of incorporation and bylaws is a structural consequence of the merger closing, making the underlying M&A activity the material event being disclosed.
View raw filing on EDGAR →
M&A activity
confidence 95%
filed 2026-05-19
Item 7.01
The filing discloses completion of a merger, which is a material acquisition or change-of-control event. Although disclosed under Item 7.01 (Regulation FD Disclosure) rather than the typical Item 1.01 or 2.01, the substance is unmistakably a merger completion announcement. The press release attached as Exhibit 99.1 confirms the merger has been completed as of May 19, 2026.
View raw filing on EDGAR →
Earnings release
confidence 95%
filed 2026-05-19
Item 2.02
The filing discloses a press release announcing "expected quarterly revenue results for its fiscal 2026 year ended March 31, 2026," which is a classic earnings release disclosure under Item 2.02. The press release is furnished as Exhibit 99.1, a standard format for earnings announcements. This is material to investors as it provides financial performance data for the fiscal year.
View raw filing on EDGAR →
Other material
confidence 65%
filed 2026-05-19
Item 2.03
This Item 2.03 disclosure reports the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of Pittsburgh. While the filing explicitly states "consolidated obligations issuance is material to the FHLBank," the disclosure is primarily informational and regulatory in nature—describing the mechanics of consolidated obligation issuance, the joint and several liability structure, and referencing Schedule A for specific debt instruments. This does not fit cleanly into covenant_breach (no violation alleged) or the more specific debt-related categories, making other_material the most appropriate classification for this regulatory debt disclosure.
View raw filing on EDGAR →
Other material
confidence 72%
filed 2026-05-19
Item 7.01
The disclosure announces initial clinical data from a Phase 2 trial (ReInspire) of zovegalisib in vascular anomalies via press release and conference call. While clinical trial results can be material to investors assessing pipeline progress and regulatory prospects, this Item 7.01 Regulation FD disclosure does not fit neatly into the earnings_release category (which typically refers to periodic financial results) nor any other specific event type. The material clinical milestone warrants classification as other_material rather than a routine administrative disclosure.
View raw filing on EDGAR →
Other material
confidence 75%
filed 2026-05-19
Item 8.01
The disclosure reports initial Phase 2 clinical trial data for zovegalisib in vascular anomalies, including efficacy results (60% volumetric response rate in 20 evaluable patients), patient-reported outcomes (89% clinical improvement in IGIC), and safety data (low Grade 3+ adverse event rates at lower doses). While this is clinical trial progress rather than a discrete event like M&A, restatement, or executive change, the positive efficacy and safety data from a Phase 2 trial would materially affect a reasonable investor's assessment of the drug candidate's development trajectory and commercial potential. The disclosure does not fit neatly into the more specific event categories (e.g., earnings_release, which typically refers to financial results), making other_material the most appropriate classification.
View raw filing on EDGAR →
Dilutive issuance
confidence 92%
filed 2026-05-19
Item 8.01
The Company disclosed a private offering of Convertible Senior Notes due 2032 to qualified institutional buyers pursuant to Rule 144A. Convertible notes are dilutive securities that may result in issuance of Class A common stock upon conversion, making this a dilutive issuance material to investors assessing capital structure and potential equity dilution.
View raw filing on EDGAR →
Exec appointment
confidence 85%
filed 2026-05-19
Item 5.02
The filing discloses multiple executive appointments on May 18, 2026: Dr. Miralles as President and Head of R&D (with $600,000 base salary, 45% bonus target, and substantial equity grants of 232,500 options and 77,500 RSUs), and Dr. Aslan as principal financial and accounting officer. While the section also includes departures (Dr. Miralles from the Board, Dr. Aslan from President, and Thad Huston as CFO), the principal disclosed actions center on the appointments of these executives to new roles with defined compensation packages, making exec_appointment the most salient classification.
View raw filing on EDGAR →
Other material
confidence 75%
filed 2026-05-19
Item 8.01
FMC announced a proposed $750 million private offering of senior secured notes due 2031 to refinance existing debt and for general corporate purposes. While this is a material financing event affecting the company's capital structure and liquidity, it does not fit cleanly into the standard taxonomy categories (not an M&A activity, not a dilutive equity issuance, not a covenant breach). The disclosure centers on the announcement of a debt offering rather than completion of a transaction, making "other_material" the most appropriate classification for this significant financing announcement.
View raw filing on EDGAR →